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Abstract: 
Background: Campy/obacter jejuni is the main cause of gastroenteritis 
worldwide. Symptoms of C. jejuni infections range from asymptomatic to bloody 
diarrhea. Previous studies showed a strong association between diversity in 
presence of bacterial virulence factors, and the different outcomes of symptoms. 
C. jejuni relies on a set of virulence factors including: Campylobacter invasion 
protein 8 (Cia8), fibronectin-binding outer membrane protein (CadF), cytolethal 
distending toxin 8 (Cdt8), Clp ATP dependent protease (CipP) and HtrB protein. 
The aim of this project was to study the association between prevalence of the 
aforementioned genes, the antimicrobial resistance patterns of the isolates, and 
the demographic data of patients. 
Methodology: A total of 17 4 archived isolates of C. jejuni were obtained 
from stool samples of symptomatic patients in the Microbiology Laboratory at 
Hamad Medical Corporation (HMC). Isolates were revived using selective media 
and DNA was extracted from positive colonies. C. jejuni isolates were screened 
by real-time PCR for the presence of five of virulence-associated genes. Isolates 
were also tested for the antimicrobial susceptibility to common antimicrobial 
agents used in HMC including: chloramphenicol, ciprofloxacin, erythromycin and 
gentamicin. Demographic data such as age, gender and nationality were also 
collected from the medical charts of subjects included in this study. 
Results: 75% of the isolates were obtained from patients younger than 5 
years old. 60.3% of the participants were males and 57% of the subjects were 
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from the Arabian Peninsula. All the virulence genes were detected with different 
percentages. There was a significant association between gender (male) and 
presence of two of the virulence genes cadF and clpP (P value: 0.022 for both). 
No clear associations were found between presence of the remaining virulence 
genes and demographic data; or between antimicrobial susceptibility patterns 
with age, gender and nationality. Isolates were highly sensitive to all antimicrobial 
agents except ciprofloxacin, where high resistance was observed. 
Conclusion: Gender (male) was strongly associated with presence of 
cadF and c/pP genes. Other correlations between prevalence of virulence genes, 
antimicrobial susceptibility and demographic data were found to be insignificant. 
Further investigation on the characteristics Campylobacter jejuni, and how they 
induce different symptoms and responses to their infection are needed . 
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Chapter 1 - Introduction 
Campy/obacter jejuni causes gastric illnesses and can in some rare cases 
cause some serious consequences. The emergence of this bacterial species as 
a significant causative agent of human disease and its ability to show 
antimicrobial resistance has made C. jejuni a serious public health concern. The 
ability of C. jejunl to colonize and survive in wide variety of animal species and 
habitats make them extremely difficult to control (Blaser et al., 1983). 
Many studies have investigated the disease mechanisms of C. jejuni 
infection. The exact mechanism of campylobacteriosis remains unknown. 
However, it is agreed that the key role players in C. jejnui pathogenesity include 
colonization of the mucous layer of the intestine, adhesion and invasion of 
intestine epithelia, and finally the production of one or more cytotoxins that are 
usually associated with the severity of the symptoms (Ketley, 1997). 
The variation in the pathogenicity among strains is a common feature in 
enterpathogens. C .jejuni strains have shown diversity in pathogenecity traits and 
factors including adhesion, invasion and toxicity. Several studies have attempted 
to associate the presence of known virulence-related genes to the disease 
phenotypes observed. Indeed there were strong associations between the 
presence of certain genes and the different outcome in phenotypic traits (AI-
Mahmeed et at., 2006). 
This dissertation discusses the background and literature of C. jejuni. It 
addresses the aspects of the human infection caused by this bacteria, 
1 
pathogenesis and virulent mechanisms. It will also discuss the antimicrobial 
susceptibility patterns of the isolates used in this study. Attempts to associate the 
presence of genes associated with pathogenesis, antimicrobial susceptibility 
testing results, and demographic data will also be discussed in details. 
Hypothesis 
In this study, we used clinical isolates of C. jejuni collected from the 
Microbiology Laboratory at Hamad Medical Corporation (HMC). Isolates were 
obtained and archived from stool samples of patients showing symptoms of 
abdominal pain, vomiting and diarrhea. 
C. jejuni relies on a set of virulence factors that are mainly involved in 
colonization and the severity of the symptoms. These factors include 
Campy/obacter invasion protein B (CiaB), fibronectin-binding outer membrane 
protein (CadF), cytolethal distending toxin B (CdtB), Clp ATP dependent 
protease (CipP) and HtrB protein. Several studies have also reported 
antimicrobial resistance of C. jejuni isolates to several antimicrobial agents. 
To our knowledge, so far no studies have investigated the prevalence of 
virulence factors or antimicrobial resistance in C. jejuni strains circulating in 
Qatar. Therefore, we hypothesize that the clinical isolates collected from HMC 
harbor the virulence factors that are vital to their pathogenesis. We also 
hypothesize that some of these isolates will have antimicrobial resistance to the 
most commonly used antimicrobial agents for treating C. jejuni infection. These 
antimicrobial agents include erythromycin, chloramphenicol, ciprofloxacin and 
2 
gentamicin. Using the demographic data of the patients, we also hypothesize 
that there might be some associations between age, gender and nationality with 
the presence of these factors, or with the antimicrobial resistance patterns. 
Aims 
The aim of this project was to characterize C. jejuni strains isolated from 
symptomatic patients referred to HMC in Qatar. C. jejuni isolates from those 
patients were screened for the presence of five of the major virulence factors of 
these bacteria that are involved in the pathogenicity of campylobacteriosis. They 
were also tested for the antimicrobial susceptibility to antimicrobial agents used 
inHMC. 
Objectives 
A. Testing the presence of the gene for the following factors: Campylobacter 
invasion protein B (CiaB), fibronectin-binding outer membrane protein 
(CadF), cytolethal distending toxin B (CdtB), ATP dependent Protease 
(CipP) and the lipid A acyltransferase protein HtrB. 
B. Determine the antimicrobial susceptibility of the clinical isolates to the 
antimicrobials routinely used to control the infection in HMC, including 
erythromycin, chloramphenicol, ciprofloxacin and gentamicin. 
C. Study the demographic data including (age, gender and nationality) and 
analyze whether or not there are any specific patterns or associations with 
objectives A and B. 
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Chapter 2 - Literature Review 
Campy/obacter jejuni is the leading cause of bacterial foodbome illness in 
humans around the world. It is even more prevalent than enteritis caused by 
Salmonella (salmonellosis) (Blaser, 1990) as it is responsible for approximately 
400 million cases of enterocolitis annually worldwide (Nachamkin et al., 1998; 
van Dijk et al., 2012). 
Chicken infection with C. jejuni is asymptomatic despite the high 
colonization rate and load (Ruiz-Palacios et al., 1981 ). In humans, however, the 
infection is symptomatic. The disease "campylobacteriosis" is caused mainly by 
the consumption of contaminated food products of chicken and sometimes 
unpasteurized milk (Silva et al., 2011 ). Symptoms can range from slightly loose 
stools to a severe bloody diarrhea. lmmunocompromised hosts develop an 
inflammatory diarrhea which usually lasts from three to five days (Dasti et al., 
201 0). The cause of this different outcome of C. jejuni infection in humans versus 
chickens is not well understood due to the lack of suitable animal models to 
mimic human campylobacteriosis (Guerry, 2007). 
Microbiology of Campylobacter jejuni 
C. jejuni belong to the family Campy/obacteraceae which include the 
genera: Campy/obacter, Arcobacter and Sulfurospiri/lum. In the genus 
Campy/obacter, there are 18 species, with some of these species considered 
pathogenic to humans (On, 2013; Vandamme and Goossens, 1992). C. jejuni is 
a small Gram-negative, non-spore forming, microaerophilic, thermophilic spiral 
4 
shaped bacterium with one or bipolar flagella (Penner, 1988). It has a relatively 
small genome (1.6-2.0 megabases) that may contribute to the inability of C. 
jejuni to ferment carbohydrates and degrade complex substances (Parkhill et al., 
2000) and may contribute to their requirement of special growth conditions and 
media (Griffiths and Park, 1990). The optimal cultural conditions of C. jejuni 
ranges from 37°C to 42°C and they strictly grow in microaerophilic atmosphere 
that consists of 3-15% oxygen and 3-5% carbon dioxide (Ketley, 1997). 
C. jejuni is known to have a chemoorganotrophic metabolism. The 
bacteria derive their energy from amino acids or from tricarboxylic acid cycle 
(Penner, 1988). Human diseases are mostly associated with catalase positive C. 
jejuni strains (Ketley, 1997).The majority of the strains have a negative reaction 
with methyl red acetone, positive for indole and hippurate hydrolysis, and reduce 
nitrate and nitrite (Sellars et al., 2002; Vandamme and Goossens, 1992). 
The complete genome sequence of C. jejuni strains and its plasmids was 
a breakthrough that started a new era of C. jejuni research. This provided 
resources for a complete and detailed analysis of the pathogenic potential of this 
bacterium and understanding the molecular basis of the virulence factors 
(Parkhill et al., 2000). 
Epidemiology 
C. jejuni infections are extremely common worldwide, although exact 
figures are not available. There are around 2.4 million cases of Campylobacter 
enteritis in the United States every year which accounts for 5 to 7% of the total 
5 
cases of gastroenteritis (Blaser, 1990; Slutsker et al., 1997). Almost 77% of the 
recorded cases of foodborne illness in the United Kingdom during 2000 were 
caused by C. jejuni (Silva et al., 2011 ). In developed countries in general, C. 
jejuni is the most commonly recognized bacterial pathogen. Its numbers even 
exceeds the combined total number for diarrheal illnesses caused by Salmonella 
, Shigella species and Escherichia coli (Blaser, 1990). The outcome of infection 
with C. jejuni in developing countries is generally different than developed 
countries. The infection is endemic especially among children younger than 2 
years old and asymptomatic infections commonly occur in older children and 
adults (Alios, 2001 ). In studies carried out in Arabian Gulf region, C. jejuni 
accounted for 1.6 to 28% of the diarrhea illness cases in the region (lsmaeel et 
al., 2002; Senok and Botta, 2009). In Qatar, a recent study focused on the 
etiology of severe acute gastroenteritis among patients visiting hospitals, 
Campylobacter was isolated from 1.04% of the stool samples tested (AI-Thani et 
al., 2013). 
Despite its clinical importance, many hospital laboratories do not culture 
routinely for C. jejuni and therefore many infections are unreported (Potter et al., 
2003). This may be due to the cost and the complex nature of the test compared 
to the other gastroenteritis causing organisms. Considering the fact that most of 
the cases are unreported, around 0.5% of the general population may have 
campylobacteriosis unknowingly (Snelling et al., 2005). Campy/obacter infections 
have no clear racial predilection and they are isolated more frequently from 
males than females (Pasternak et al., 1984). However, studies have shown that 
6 
there is a high incidence of C. jejuni infection in children who are younger than 1 
year and in people aged between 15 to 29 years (Martin et al., 1989). In the 
United States, the highest incidence of Campylobacter infection in 2010 was in 
children younger than 5 years (Nyati and Nyati, 2013) and in developing 
countries, the infection is also most common in the first 5 years of life (Alios, 
2001). 
Source and Transmission of Infection 
C. jejuni can live in the intestine of livestock as a part of the normal flora. 
These animals include poultry, cattle, sheep, and swine (Penner, 1988). C. jejuni 
can directly infect humans by ingestion of contaminated food products of animal 
origin and consumption of untreated and infected water. However, the 
consumption and handling of contaminated chickens remains the single most 
important route of Campylobacter infection. Studies from the United States 
(Harris et al., 1986 , Europe (Jore et al., 2010), and Australia (Stafford et al., 
2008) have estimated that 50 to 70% of the human infections could be due to the 
consumption of chicken. It has been estimated that one drop of the chicken juice 
contains 500 infectious organisms which might be sufficient to cause infection as 
C. jejuni has a low infective dose (Black et al., 1988; Harris et al., 1986). C. jejuni 
bacteria can't survive under very high temperatures, so good cooking of chicken 
is emphasized as measure of food safety (Blaser et al., 1983). 
7 
Symptoms and Complications 
Soon after exposure to C. jejuni, the lower intestinal tract (including ileum, 
jejunum and colon) might become colonized without symptoms. However, in 
symptomatic cases the disease is self-limiting and is presented with 1 to 3 days 
of fever, vomiting, headaches followed by 3 to 7 days of watery or bloody 
diarrhea, bowel movements, and abdominal pain (Dasti et al., 2010). Most of 
these signs are common to other acute gastrointestinal infections cause by other 
enteric pathogens and therefore are clinically indistinguishable (AI-Thani et al., 
2013). 
There is a great variety in the severity of the disease which ranges from 
mild symptoms to sever dehydration that may require hospitalization. Some of 
the complications associated with campylobacteriosis include reactive arthritis, 
bacteremia, endocarditis, cholecystitis, urinary tract infection, pancreatitis and 
Guillain-Barre syndrome (GBS) (Alios, 2001 ). GBS is a serious, fatal autoimmune 
disorder which occurs when the body's immune system mistakenly attacks part of 
the nervous system (Godschalk et al., 2004). Lipooligosaccharide structure of C. 
jejuni resembles human neuronal ganglioside and that may lead to this 
autoimmune disorder that approximately affect 1 in every 1,000 cases of 
campylobacterosis (Hughes, 2004 ). 
Without complications, deaths are rare and most of death cases are in 
infants, elderly and patients with underlying illnesses (Alios, 2001 ). 
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Diagnosis 
C. jejuni is a slowly growing fastidious Gram negative organism that 
requires specific incubation conditions. Methods used for identification of C. jejuni 
involve the use of selective culture media with the combination of biochemical 
tests like hippurate hydrolysis. Selective media are very useful for the initial 
isolation of Campy/obacter, however biochemical methods of identification are 
necessary for confirmation (Englen and Fedorka-Cray, 2002; Wang et al., 2002). 
Selective media include blood-free media (such as charcoal cefoperazone 
deoxycholate agar) or blood containing media like Skirrow media (Corry et al., 
1995). Isolation of the organism is done by culturing it in microaerophilic 
conditions and in incubation temperature of 42°C on a selective media. To 
enhance the recovery of C. jejuni from a stool sample, the use of enriched broth 
cultures has been recommended (Cox et al., 2001 ). 
Several investigators have introduced the application of multiplex 
polymerase chain reaction (PCR) for the identification of C. jejuni infection. Their 
approach focuses on using specific virulence related genes for identifications. 
However, these protocols still required the conventional methods for isolating the 
organism using selective media and DNA extraction (AI Amri et al., 2007). A 
recent study has come up with a novel approach in which they used multiplex 
PCR by combining genus specific virulence genes such as cadF with species 
specific genes such as hipO to detect C. jejuni directly from stool specimens (AI 
Amri et al., 2007). This procedure has a turnaround time of 6 hours (from DNA 
extraction to gel electrophoresis) whereas the conventional methods require two 
9 
to five days (LaGier et al., 2004 ). Therefore, the use of molecular techniques can 
improve the clinical management and epidemiological tracking of Campylobacter 
infections. 
Pathogenesis and Virulence Factors 
The exact steps of C. jejuni infection that cause enteritis in humans are 
still unknown. However, the requirements for C. jejuni virulence have been 
observed and they include motility (Guerry, 2007), resistance to antimicrobials 
(Moore et al., 2006b), adherence to host cells and invasion (Konkel et al., 2001 ), 
alteration of the host cell signaling pathways and induction of host cell death 
(Hickey et al., 2000), and finally iron acquisition (van Vliet et al., 2002). 
In the human host, cellular injury happens as a result of cell invasion 
which leads to reduction in the absorptive capacity of the intestine, whereas CDT 
plays a major role in the release of interlukin-8 which has an important role in the 
host mucosal inflammatory response caused by C. jejuni (Hickey et al., 2000). 
CDT consists of three subunits: the catalytic part CdtB, and the binding proteins 
CdtA and CdtC, which deliver CdtB into the nucleus of target cells (Hickey et al., 
2000). Genotoxic effects on the host DNA is induced by the translocation of CdtB 
to the nucleus which in turn triggers the DNA repair cascade that lead to cell 
cycle arrest and eventual cell death (Jain et al., 2008; Konkel et al., 2001) 
C. jejuni synthesizes a set of proteins known as Campy/obacter invasion 
antigens (Cia proteins) that contribute to the invasion of epithelial cells (Konkel et 
al., 1999; Konkel et al., 2004). The mechanism of secretion of these antigens 
10 
(mainly CiaB) and their exact role in invasion has been linked to the model of 
type Ill secretion systems, in which effectors are injected directly into host cells 
(Guerry, 2007). However, C. jejuni does not encode a type Ill secretion system, 
(Rivera-Amill et al., 2001) but utilizes a flagellar export apparatus to secrete the 
Cia set of proteins CiaA-H (Konkel et al., 2004). FlaC another protein required 
for invasion is also secreted from the flagellar export apparatus of C. jejuni 
(Konkel et al., 2004). 
For adherence to intestinal epithelial cells, C. jejuni possesses a 37 kDa 
adhesion protein, called fibronectin-binding outer membrane protein (CadF) that 
binds to the cell matrix protein fibronectin and supports the adherence of C. jejuni 
to the intestinal epithelial cells (Konkel et al., 1997). 
The diversity of the clinical outcome of infection by different isolates of C. 
jejuni could be related to the difference in their genetic composition (Carvalho et 
al., 2001 ). In 2006, molecular characterization of C. jejuni isolates from Bahrain 
showed a significant relationship between the presence of combinations of 
virulence genes and the severity of symptoms. C. jejuni strains that were positive 
for more than one of the virulence genes such as cia, iam and cdtB were isolated 
from patients with the most severe infections (AJ-Mahmeed et al., 2006). 
However, the isolates which were negative for cdtB and iam still caused clinical 
symptoms among children Jess than 3 years old. This could be due to other 
unidentified virulence genes that have an effect on the clinical outcome (AI-
Mahmeed et al., 2006). 
11 
Response to Stress 
Due to its complex nutritional requirements, C. jejuni has limited capacity 
of growth in the environment. Unlike other enteric pathogens, C. jejuni lacks 
many adaptive responses which make it sensitive to different environmental 
stress (Hofreuter et al., 2008). The genome analysis of Campy/obacter jejuni 
showed that it lacks the global regulator RpoS which is essential for the survival 
of many Gram negative bacteria during exposure to environmental stress 
(Parkhill et al., 2000). However, it has been shown that Campy/obacter can 
somehow adapt to both acidic and aerobic conditions (Chaveerach et al., 2003). 
Exposure to acidic conditions may trigger a conversion of C. jejuni into a viable 
but non-culturable (VBNC) form (Murphy et al., 2003). 
During the transmission of C. jejuni from its primary reservoirs to the 
consumer, the bacteria become exposed to environmental changes like oxygen 
availability and temperature fluctuations. The bacterium has to adapt to these 
changes in order to survive (Cohn et al., 2007). The consequences that follow 
these changes trigger the production of chaperones and proteases that play vital 
roles in the survival of the bacteria by refolding or degrading the proteins that 
have been damaged by stress. ClpP is an ATP dependent protease that 
degrades the stress damaged proteins in an energy dependent manner 
(Hlavacek and Vachova, 2002). 
Another gene that is essential for C. jejuni is the htrB gene which is 
located in the lipo-oligosaccharide synthesis gene cluster and encodes an 
12 
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acyltransferase that contributes to lipid A synthesis (Gilbert et al., 2002; Parkhill 
et al., 2000). This gene plays a major role in regulating how the organism 
responds to various environmental changes (Phongsisay et al., 2007). 
Resistance to Antimicrobials 
C. jejuni infection is self-limiting and does not require treatment in most 
cases. Maintaining hydration and electrolytes balance are the cornerstone 
treatment for this infection (Kirkpatrick and Tribble, 2011 ). However, there are 
some cases that require the use of antimicrobial agents. These cases include 
high fever, prolonged illness that last more than a week and bloody diarrhea 
(Kirkpatrick and Tribble, 2011 ). 
The antimicrobial agent of choice for Campylobacter infections is 
erythromycin followed by ciprofloxacin(Nachamkin et al., 2002). Despite being 
used for decades, now C. jejuni showed low rates of resistance to erythromycin 
(Nachamkin et al., 2002). The advantages of this antimicrobial agent include its 
low cost, easiness and safety of administration in addition to having a narrow 
spectrum of activity. Also unlike fluoroquinolones and tetracyclins, it is safe to 
administer erythromycin to children and pregnant women and is less likely to 
cause inhibition of normal flora (Saenz et al., 2000).The excessive use and the 
administration of fluoroquinolones to animals' feed in countries like Holland, 
Finland, and Spain have led to an increase to antimicrobial resistance among C. 
jejuni strains (Endtz et al., 1991 ). Also in the UK, the approval of using 
13 
vi 
·(666~ '·Je ta wes) 6nJp a4l 
Ol aouets!SSJ uewn4 U! aseaJOU! ue U! patJnsaJ stad O!tsawop U! saUOJOU!nboJonu 
• 
• 
• 
• 
• 
• 
• 
Chapter 3 - Materials and Methods 
Ethical Approval 
Human clinical samples were used in this study. Ethical approval was 
obtained from the Medical Research Center at Hamad Medical Corporation, 
protocol number: 13334/13. 
Sample Size 
The sample size of this study was 17 4 C. jejuni clinical isolates. These 
isolates were obtained from stool specimens of outpatients showing symptoms of 
severe diarrhea presented to Hamad General Hospital. Campylobacter culture 
was done at the Microbiology Laboratory of HMC only for specimens of patients 
who had at least three episodes of sever diarrhea in one day. After confirmation 
of C. jejuni infection by using selective media and biochemical testing, positive 
isolates were cryopreserved on beads and stored at -80 °C in 1 % (w/v) proteose 
peptone water containing 10 % (v/v) glycerol until required. Isolates were 
collected in the period between 2005 and 2011. 
Bacteria Culture 
The revival of the archived samples was carried out using standard 
microbiological methods used in HMC. C. jejuni isolates were cultured on 
selective Colombia agar plates (Sigma) and they were grown under 
microaerophilic conditions using Campy GasPak (BD) at 42°C for 48 hours in an 
anaerobic jar (BD). Growing colonies were checked for morphology, color, and 
15 
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size. Only colonies grey or colorless, pinpoint flat or mucoid to convex were used 
for DNA extraction 
DNA Extraction 
DNA was extracted from C. jejuni isolates following standard molecular 
biological techniques. Qiagen's mericon DNA Bacteria Kit was used according to 
the manufacturer's recommended procedures. Positive colonies were suspended 
with 1 ml of water and collected in a 2 ml microcentrifuge tube then centrifuged at 
13,000 x g for 5 min. The supernatant was discarded using a pipet, taking care to 
not disrupt the pellet. After that, 200 J,JI of fast lysis buffer was added to the pellet 
and the pellet was resuspended by vigorous vortexing. Microcentrifuge tubes 
were placed into a thermal shaker with 800 rpm and a temperature set to 1 00°C 
for 10 minutes. The samples were later allowed to cool down for 2 minutes to 
. 
room temperature (15 - 25°C).Tubes were centrifuged at 13,000 x g for 5 
minutes. A total of 100 J.JI of the supernatant was transferred to a fresh 1.5 ml 
microcentrifuge tube and stored at -Boac until used for PCR reaction. 
Real-time PCR 
RT -PCR was performed using the DNA extracted from the clinical isolates. The 
primers (Table 1) were designed using primer design software based on 
available sequences in GenBank. The primers were tested on C. jejuni ATCC 
33560 strain to confirm their efficiency. For each reaction the following conditions 
were used: A total of 7 J.JI of Sybrselect (LifeTechnologies} master mixture was 
used in each reaction along with 0.3 J,JI primer mixture, 2.5J.JI specimen DNA, and 
16 
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10.21JI molecular grade water. RT-PCR cycles consisted of holding for 2 minutes 
• at 95°C, followed by 40 cycles of 95°C for 15s, 55°C for 35 sec, and 72°C for 1 
minute. The cycling conditions for the RT-PCR run is shown in (Table 2) 
Table 1: Primers for virulence genes used in this study . 
• 
- Primers Sequence (5.·31 
Forward TAT GGT GTA GAA AAA AGT CGC ATC A 
cadF I 
Reverse ATC CGC TCT ACC TTC TTT AGT GTC A 
Forward AAT GCA AGC TGA AGA AGT GAT TGT 
cdtB I 
Reverse AGC ATC ATT TCC ATT GCG AAT 
Forward CAA CTT TAT ATT TGC ACT CCG ATG 
ciaB I 
Reverse GGA ACG ACT TGA GCT GAG AAT AAA C 
Forward TGG GAG CAT TTT TGC TTA GTT G 
I 
c/pP 
I 
Reverse CTC CAC CTA AAG GTT GAT GAA TCA T 
Forward CGC ACC CAA TTT GAC ATA GAA C 
htrB I 
Reverse TTT TT A GAG CGC TT A GCA TIT GTC T 
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Table 2: RT -PCR cycling conditions. 
Step Time Temp 
Initial heat activation 5min 95 
Denaturing 30 seconds 94 
Annealing 40 seconds 60 
Extension 60 seconds 72 
Number of cycles 42 
Antimicrobial Susceptibility Testing 
Minimum inhibitory concentration MIC of antimicrobial agents was 
determined using the Epsilometer test (bioMerieux). This test uses a rectangular 
strip that is impregnated with the targeted antimicrobial agents including 
chloramphenicol, ciprofloxacin, erythromycin and gentamicin. Isolate to be tested 
was suspended in Brain-Heart Infusion broth and vortexed briefly. The bacteria 
was spread and grown on an agar plate, and the strip was laid on top. The 
antimicrobial agents diffused into the agar, making an exponential gradient of the 
targeted agents. On the strip there is an exponential scale. After incubation for 24 
hours, an elliptical zone of inhibition was seen on the plate and the point at which 
the ellipse meets the strip gave the reading forMIC. 
Demographic Data 
Information about age, gender and nationality were collected from the 
electronic medical records of HMC (Medicom). Each subject was assigned a 
unique identifying code number and patients' identities were not disclosed in the 
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collected data. All papers and files concerning the study were kept locked in a file 
cabinets and they were only accessible by the investigators. All data were stored 
on a password-protected computer that is accessible only by the research team. 
No identifying information appeared in any of the publications or reports and the 
data will be destroyed upon the completion of this study. 
Statistical Analysis and Validation 
Variables studied in this project included: Age, which was continuous and 
obtained from the Electronic Medical Records of HMC, gender, nationalities 
which were divided into 4 groups (1. Arabian Peninsula, 2. East and North 
Africans, 3. Asians and 4. Others), virulence genes categorized as (presence I 
absence) and finally the results of antimicrobial susceptibility testing which were 
categorized as (sensitive I resistant). 
The sample size of this project was 17 4 clinical isolates of C. jejuni. Only 
samples which were positive after the reviving and sub-culturing were included in 
this study and a number of 14 samples of negative culture were excluded. Data 
were entered into an excel sheet and significance of associations between the 
variables was tested through bi-variable analysis using Pearson Chi-square test. 
Fisher exact test was employed for small size samples especially in the sub 
groups of age and nationalities. P values less than 0.05 were considered 
significant. Analysis was performed using IBM SPSS software, version 22.0. 
19 
• 
• 
Chapter 4- Results 
Demographic Characteristics of the Study Population 
Age Distribution 
The distribution of patients according to age was as the following: Group 1 
(5 :?;) contained the majority of patients as it accounted for 75% of them, Group 2 
(6 - 20) 12.6%, Group 3 (21 - 60) 8.6%, and finally Group 4 (61 S) which 
contained the least number of patients (3.4%)(Table 3). 
Gender Distribution 
Out of 174 isolates, the prevalence of C. jejuni in males was higher as 
60.3% of the isolates came from males while 39.7% were obtained from females 
(Table 3). 
Patient Nationality Distribution 
Subjects were classified according to their nationalities into 4 groups. 
Group 1 included people from the Arabian Peninsula. Group 2 had subjects who 
are originally from North and East Africa. Group 3 were Asians and the Group 4 
contained people living in areas other than the above mentioned. In the present 
study, the majority of patients were from the Arabian Peninsula (57%) followed 
by Asians (28% ), while East and North Africans comprised 11.5% and people 
from other origins accounted for only 3.5% (Table 3). 
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• Table 3: Demographic characteristics of the study population including age 
groups, gender and nationalities. 
No. of patients(%) 
Age groups 
5~ 131 (75) 
6-20 22 (12.6) 
21-60 15 (8.6) 
61S 6 (3.4) 
Median age: 2 (0.08 - 75) years. 
Gender 
Male 105 (60.3) 
Female 69 (39.7) 
Nationalities 
Arabian Peninsula 99 (57) 
East and North Africans 20 (11 .5) 
Asians 49 (28) 
Others 6 (3.5) 
Antimicrobial Susceptibility Testing 
All clinical isolates were tested for their antimicrobial susceptibility to the 
antimicrobial agents commonly used at HMC which contained: chloramphenicol, 
ciprofloxacin, erythromycin and gentamicin. Apart from ciprofloxacin, all isolates 
were highly sensitive to the antimicrobials with percentages above 90%. All 
isolates were susceptible to gentamicin (Table 4 ). 
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Table 4: Antimicrobial susceptibility testing results for C. jejuni isolates. 
Chloramphenicol Ciprofloxacin Erythromycin Gentamicin 
n (%) n (%) n (%) n (%) 
Sensitive 173 (99.4) 64 (36.7) 159 (91.4) 174 (100) 
Resistant 1 (0.6) 110 (63.3) 15 (8.6) 0 (0) 
Prevalence of Virulence Genes 
Presence of the virulence-related genes cadF, cdtB and ciaB in the 
isolates was determined. cdtB was the most prevalent (87.36%) followed by ciaB 
(71.8%) and finally cadF (59.8%)(Table 5). Stress response genes, c/pP and 
htrB, were also examined and both were detected in the C. jejuni isolates with 
percentages of67.8% and 83.3%, respectively (Table 5). 
Table 5: Prevalence of virulence genes in C. jejuni isolates. Of the five genes, 
cdtB was the most prevalent while cadF was the least. 
Virulence Genes 
ciaB 
cadF 
cdtB 
htrB 
clpP 
No. of isolates positive for each gene 
by RT -PCR (%) 
125 (71.8) 
104 (59.8) 
152 (87.36) 
118 (67.8) 
145 (83.3) 
Further analysis was done to study the presence of more than one gene of 
the genes associated with the virulence mechanism at the same C. jejuni strain. 
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Almost 65% of the isolates harbored both ciaB and cdtB, while 51.7% had the 
genes cadF and ciaB and 55.1% carried cadF and cdtB. Only 33.9% of the 
isolates expressed all the virulence genes tested in this study at the same time 
(Table 6). 
Table 6: Prevalence of virulence factors genes combination in same C. jejuni 
isolate. The most prevalent gene combination was ciaB and cdtB, while ciaB and 
cadF combination was the least prevalent. 
Virulence Genes 
ciaB (+), CadF (+), cdtB (+) 
ciaB (+), CadF (+) 
ciaB (+), cdtB (+) 
cadF (+), cdtB (+) 
c/pP (+), htrB (+) 
No. of isolates positive for genes by RT • 
PCR(%) 
59 (33.9) 
90 (51.7) 
113 (64.9) 
96 (55.1) 
105 (60.34) 
Association of Virulence Gene Presence with Gender, Age and Nationality 
The next approach was to examine whether there are any associations 
between the presences of the target genes and the demographic data collected 
from the patients including gender, age and nationality. There was a significant 
association between the gender (male) and the presence of cadF and clpP 
genes with a P value of 0.022 for both. However there was no significant 
correlation between the gender and remaining genes. Also there were no clear 
associations between patients' nationalities and the presence of both virulence 
genes (Table 7). Furthermore, the presence of the genes studied in this project 
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was tested for associations with the different age groups. However no significant 
association was found between presence of target genes and age. 
Table 7: Distribution of virulence gene presence by gender, age groups and 
nationality. 
cadF(+) claB (+) cdtB (+) clpP(+) htrB (+) 
(104) (125) (152) (145) (118) 
n (o/o) n (%) n (o/o) n (o/o) n (%) 
Gender 
Male (105) 70 (66.7)* 80 (76 .2) 95 (90.5) 93 (88.6)* 71 (67.6) 
Female (69) 34 (49.3) 45 (65.2) 57 (82.6) 52 (75.4) 47(68.1) 
Age groups 
5~(131) 81 (61.8) 97 (74) 114 (87) 109 (83.2) 89 (67.9) 
6-20 (22) 10 (47.6) 10 (47.6) 19 (90.5) 18 (85.7) 13 (61.9) 
21-60 (15) 9 (64.3) 12 (85.7) 11 (78.6) 11 (78.6) 9 (64.3) 
61S (6) 6(75t 7 (87.5)8 8 (100t 7 (87.5)8 7 (87.5t 
Nationality 
Arabian Peninsula (99) 61 (62.2) 73 (74.5) 87 (88.8) 81 (82.7) 64 (65.3) 
East and North Africans (20) 13(61 .9) 13 (61 .9) 17 (81) 14 (66.7) 12 (57.1) 
Asians (49) 24 (49) 34 (69.4) 42 (85.7) 45 (91.8) 36 (73.5) 
Others (6) 6 (100)8 5 (83.3)8 6 (100)8 5 (83.3)8 6 (100)8 
*Using Pearson chi square, P value < 0 .05 was considered signifrcant. 
a Fisher exact test was used for small size samples. 
Association of Antimicrobial Susceptibility with Gender, Age and 
Nationality 
For antimicrobial sensitivity in relation to patient gender and nationality, 
no significant associations were recorded (Table 8). Also, antimicrobial 
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susceptibility results did not have any significant associations with the different 
age groups included in this study (Table 8). 
Table 8: Distribution of antimicrobial sensitivity by gender, age and nationality. 
Chloannphenicol Ciprofloxacin Erythromycin Gentamicin 11" 
(173) (69) (159) (174) 
n (%) n (%) n (%) n (%) 
Gender 
Male(105) 104 (99) 41 (39) 97 (92.4) 105 (100) 
Female (69) 69 (1 00) 23 (33.3) 62 (89.9) 69 (100) 
Age groups 
5<!:(131) 130 (99.2) 51 (38.9) 120 (91.6) 131 (100) 
6-20 (22) 22 (100) 7 (31 .8) 20 (90.9) 22 (100) 
21-60 (15) 15 (100) 5 (33 .3) 13 (86.7) 15 (100) 
61S (6) 6 (100)b 1 (16.6)b 6 (100t 6 (100)b 
Nationality 
Arabian Peninsula (125) 98 (100) 39 (39.8) 89 (90.8) 98 (100) 
East and North Africans (20) 21 (1 00) 8 (38.1) 18 (85.7) 21 (100) 
Asians (49) 48 (98) 15 (30.6) 46 (93.9) 49 (100) 
Others (6) 6 (100)b 2 (33.3)b 6 (100)b 6 (100)b 
8
• No statistics are computed because gentamicin is constant (all isolates were sensitive). 
b. Fisher exact test was used for sman size samples. 
*Using Pearson chi square, P values< 0.05 was considered significant. 
Association of Antimicrobial Susceptibility with Presence of Target Genes 
We tested whether the difference in prevalence of the different genes 
studied in this project has a role in the antimicrobial susceptibility patterns. No 
significant correlations were found between the results of antimicrobial 
susceptibility test and the prevalence of the virulence genes. However, it seems 
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that there is a weak association of ciprofloxacin resistance with the presence of 
the gene htrB (P value 0.069) (Table 9) . 
• Table 9: Virulence genes presence by antimicrobial sensitivity. 
Antimicrobial Agents cadF(+) claB (+) cdtB (+) clpP (+) htrB (+) 
n (%) n (%) n (%) n (%) n (%) 
Chloramphenicol 103 (59.5) 124(71.7) 151 (87.3) 144 (83.2) 117 (67.6) 
C iprofloxacin 35 (54.7) 43 (67.2) 57 (89.1) 55 (85.9) 80 (72.7) 
Erythromycin 97 (61) 114 (71 .7) 140 (88.1) 135 (84.9) 110(69.2) 
Gentamicin 104 (59.8)8 125 (71.8)8 152 (87.4)8 145 (83.3)8 118 (67.8)8 
a. The correlation was not tested in gentamicin because all of the isolates were sensitive to the agent. 
*Using Pearson chi square, P value< 0.05 was considered significant. 
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Chapter 5 - Discussion 
Campylobacter jejuni remains a major cause of gastroenteritis worldwide. 
The emergence of these bacteria as a main source for human disease and their 
ability to show antimicrobial resistance patterns have contributed in making C. 
jejuni infections a serious public health concern (Dasti et al., 2010). 
Most of the studies that have focused on the prevalence of Campylobacter 
jejuni virulence associated genes were done using isolates from Europe, United 
States and Latin America (Gonzalez-Hein et al., 2013). As far as we know, no 
previous research was done using isolates from Qatar. In this study, a total of 
17 4 C. jejuni isolates were tested for the presence of several virulence and 
stress-response factors in addition to antimicrobial resistance for the agents 
commonly used at HMC. These samples were archived by the Microbiology 
Laboratory at HMC during the period from 2005 to 2011. 
Our findings showed that subjects who were five years old or younger 
were the most vulnerable population for C. jejuni infection as 75% of the patients 
in this study belonged to this age group. This finding is consistent with previous 
studies done in the United States (Nyati and Nyati, 2013) and in several 
developing countries (Alios, 2001; Kotloff et al., 2013). In our findings, the slight 
predominance of male subjects (60.3% to males and 39.7% to females) was also 
consistent with gender-related susceptibility to C. jejuni infection in previous 
studies (Alios, 2001 ). The reason of this specific age and gender distribution 
remains unknown. 
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In this study, 57% of C. jejuni isolates belonged to subjects from Arabian 
Peninsula followed by Asians with 28%, then East and North Africans (11.5%) 
and finally subjects from other nationalities (3.5%). Although the numbers of 
expatriates in Qatar exceeds the number of nationals, our results showed that 
the majority of subjects were from Arabian Peninsula. This predominance could 
be due to access to health services rather than any true epidemiological 
differences. 
The pathogenicity of C. jejuni is complex and multi-factorial as several 
genes are involved in the progression of the disease (Ketley, 1997). In this study, 
five virulence associated genes have been investigated in isolates collected from 
the Microbiology Laboratory at HMC. The genes investigated in this study were: 
cadF, cdtB, ciaB, clpP and htrB. They are important for adhesion, toxin 
production, invasion and stress response (van Vliet and Ketley, 2001 ). The 
genes of interest were detected in all C. jejuni isolates from HMC with different 
frequencies. cdtB gene was by far the most prevalent as it was present in 87.3% 
of the isolates. cdtB encodes the catalytic part of CDT, which is responsible for 
the genotoxic effect on the DNA of the cell (Hickey et al., 2000; Jain et al., 2008; 
Konkel et al., 2001 ). The CdtB subunit along with the two binding subunits, CdtA 
and CdtC, forms the CDT protein which also induces an inflammatory response 
at the mucosal surfaces (Hickey et al., 2000). ciaB was also present in 71.8% of 
C. jejuni isolates. Out of the 9 Campylobacter invasion antigens, (CiaA-H), CiaB 
is probably the most important protein as its deletion abolishes the ability of C. 
jejuni to invade cells (Konkel et al., 1999; Konkel et al., 2004). C. jejuni does not 
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encode a type Ill secretion system, (Rivera-Amill et al., 2001) but utilizes a 
flagellar export apparatus to secrete the Cia set of proteins and other proteins 
and inject them directly into host cells (Guerry, 2007; Konkel et al., 2004). The 
high prevalence of cdtB and ciaB genes is consistent with other studies where 
these two genes are generally widespread among isolates from humans with 
clinical symptoms (Feamley et al., 2008). The prevalence of cadF gene, 
however, was only 59.8% in the isolates. This finding was inconsistent with oth~r 
studies where cadF was found to approach a prevalence of 100% in C. jejuni 
clinical isolates (Feamley et al., 2008). The two genes responsible for stress 
response clpP and htrB were also present with frequencies of 83.3% and 67.2% 
respectively. In Escherichia coli, mutation of htrB, which encodes a lipid A 
acyltransferase, causes a variety of effects that include a change in the 
morphology of rods (Karow et al., 1991 ), growth inhibition at higher temperatures 
(Karow et al., 1991 ), and several fold-increase in bile (Karow and Georgopoulos, 
1992). The same effects are observed in Salmonella in addition to 
hyperflagellation and loss of virulence (Jones et al., 1997). In Haemophi/us 
influenzae, knockout of htrB did not affect the morphology of the bacterium but 
rather its ability to colonize and survive intracellularly (Swords et al., 2002). The 
deletion of htrB in C. jejuni reduces its capacity to grow well at the higher 
temperature of 42°C, which is the body temperature of chickens (Phongsisay et 
al., 2007). The deletion of this gene also affected C. jejunls resistance to acid 
and osmotic pressure (Phongsisay et al., 2007). This reflects the importance of 
these genes for the growth of C. jejuni in gastrointestinal tract of humans. 
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Infections caused by C. jejuni are typically self-resolving and they do not 
require treatment. However in severe cases, the administration of antimicrobial 
agents may be necessary for patients with prolonged and systemic infections 
(Kirkpatrick and Tribble, 2011 ). Macrolides like erythromycin and 
fluoroquinolones like ciprofloxacin are currently considered the antimicrobial 
agents of choice (Siutsker et al., 1997). However, recent studies showed varying 
patterns of Campylobacter resistance to antibiotics in different regions. 
Furthermore, there is a concern about the widespread use of antimicrobial 
agents such as erythromycin, ciprofloxacin and tetracycline in animal feed. This 
has helped the generation of several C. jejuni strains that are resistant to 
antibiotics (Moore et al., 2006a). In HMC, the list of common antimicrobial 
agents used to control the infection include: erythromycin, ciprofloxacin, 
chloramphenicol and gentamicin. The antimicrobial susceptibility patterns were 
tested in the clinical isolates. Isolates were highly sensitive to three out of the 
four antibiotics tested in this study: chloramphenicol, gentamicin and 
erythromycin. In the case of gentamicin, there was no resistance as all the 
isolates were sensitive to this agent. This was consistent with studies done in 
New Zealand and the United States where isolates were sensitive to this 
antimicrobial (Moore et al., 2006a). On the other hand, 64.7% of the isolates 
were resistant to ciprofloxacin. Ciprofloxacin resistance was also determined in 
studies carried out in South Africa and Lebanon (Moore et al., 2006a). A strong 
association has been observed between the licensing of fluoroquinolones for use 
in animal feed in Europe and the increase of antimicrobial resistance against this 
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particular agent (Endtz et al., 1991 ). The same link was also made in the United 
Kingdom when this family of drugs was used in pets as human isolates started 
showing resistance (Sam et al., 1999). Based on our findings, imply the 
usefulness of erythromycin as the drug of choice in HMC. 
One of the main goals of the study was to test associations between the 
prevalence of virulence genes and demographic data collected from the patients. 
A significant association between gender (male) and the presence of the genes 
cadF and clpP (P value: 0.022) was seen. However the same was not found in 
the remaining genes. Also in our study, the antimicrobial susceptibility patterns 
had no clear associations with demographic data (age, gender and ethnicity). 
The analysis was carried out only for ciprofloxacin as the number of isolates 
resistant to other agents was not sufficient to perform a meaningful statistical 
analysis. The association between the prevalence of the different genes and 
whether or not they have an influence on the antimicrobial susceptibility patterns 
revealed no significant association between antimicrobial sensitivity and the 
prevalence of virulence genes. A limitation to the study was the small sample 
size of the sub-groups of age and nationality. This has made it difficult to come 
up with conclusive results for the tested associations. 
When it comes to the pathogenesis of C. jejuni infection, little is 
understood. The prevalence of C. jejuni virulence genes and their relationship 
with the severity of symptoms in humans should be further investigated. As 
HMC's electronic medical records do not include symptoms of their data and 
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paper files information were not consistent, an analysis for the association of the 
symptoms with the prevalence of virulence factors was not carried out. 
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Chapter 6 - Conclusion 
Using relatively significant number of C. jejuni isolates, we have shown 
that the main virulence and stress response genes were present in isolates 
collected from HMC hospital. The fact that these isolates showed antimicrobial 
resistance only towards ciprofloxacin but were highly sensitive to 
chloarmphenicol, gentamicin and erythromycin suggests that the use of this 
agent in animals is probably contributing to the spread of its resistance. Indeed, 
laws in Qatar allow the use of enrofloxacin, a related fluoroquinolone, in the 
poultry industry. Since C. jejuni remains a major source and cause of enteritis in 
Qatar and around the world, further investigation of the molecular characteristics 
of these bacteria, and how they induce different clinical manifestations and 
responses to infection is needed. 
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